These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 36393842)
1. Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer. Cao X; Zhou X; Chen C; Wang Z; Sun Q Front Cell Dev Biol; 2022; 10():962389. PubMed ID: 36393842 [TBL] [Abstract][Full Text] [Related]
2. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer. Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247 [TBL] [Abstract][Full Text] [Related]
3. Identification of immunogenic cell death-related subtypes used for predicting survival and immunotherapy of endometrial carcinoma through a bioinformatics analysis. Liu Z; Luo Y; Su L; Hu X Medicine (Baltimore); 2023 Aug; 102(31):e34571. PubMed ID: 37543760 [TBL] [Abstract][Full Text] [Related]
4. A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer. Dong B; Wu Y; Zhang J; Gu Y; Xie R; He X; Pang X; Wang X; Cui Y Front Immunol; 2023; 14():1162876. PubMed ID: 37215130 [TBL] [Abstract][Full Text] [Related]
5. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas. Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y Front Immunol; 2023; 14():1102094. PubMed ID: 37153540 [TBL] [Abstract][Full Text] [Related]
6. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma. Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma. Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C Front Immunol; 2022; 13():1071636. PubMed ID: 36569869 [TBL] [Abstract][Full Text] [Related]
8. Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer. Kang Z; Sun JB; Lin F; Huang XY; Huang Q; Chen DN; Zheng QS; Xue XY; Xu N; Wei Y Front Oncol; 2023; 13():1160972. PubMed ID: 37346077 [TBL] [Abstract][Full Text] [Related]
9. Machine learning-based construction of immunogenic cell death-related score for improving prognosis and response to immunotherapy in melanoma. Li G; Zhang H; Zhao J; Liu Q; Jiao J; Yang M; Wu C Aging (Albany NY); 2023 Apr; 15(7):2667-2688. PubMed ID: 37036471 [TBL] [Abstract][Full Text] [Related]
10. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
11. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
12. An immunogenic cell death-related classification predicts response to immunotherapy and prognosis in triple-negative breast cancer. Cheng XY; Liang Y; Zhang HF; Qian FZ; Sun XH; Liu XA Am J Transl Res; 2023; 15(4):2598-2609. PubMed ID: 37193173 [TBL] [Abstract][Full Text] [Related]
13. Definition of a Novel Immunogenic Cell Death-Relevant Gene Signature Associated with Immune Landscape in Gastric Cancer. Meng Y; Jin Z; Wang M; Chen D; Zhu M; Huang Y; Xia S; Xiong Z Biochem Genet; 2023 Oct; 61(5):2092-2115. PubMed ID: 36943521 [TBL] [Abstract][Full Text] [Related]
14. Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas. Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z Cells; 2022 Nov; 11(22):. PubMed ID: 36429083 [No Abstract] [Full Text] [Related]
15. Construction and comprehensive analysis of a novel prognostic signature associated with immunogenic cell death molecular subtypes in patients with bladder cancer. Gu L; Hu G; Hu J; Wen F Heliyon; 2023 Aug; 9(8):e18848. PubMed ID: 37593621 [TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients. Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive analysis of immunogenic cell death and its key gene HSP90AA1 in bladder cancer. Song Q; Zhou Z; Bai J; Liu N Clin Transl Oncol; 2023 Aug; 25(8):2587-2606. PubMed ID: 37000291 [TBL] [Abstract][Full Text] [Related]
18. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma. Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q Front Immunol; 2022; 13():1011757. PubMed ID: 36325335 [TBL] [Abstract][Full Text] [Related]
19. Development of an immunogenic cell death-related lncRNAs signature for prognostic risk assessment in gastric cancer. Li W; Ding F; Zhang J Transl Cancer Res; 2024 Aug; 13(8):4420-4440. PubMed ID: 39262480 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy. Li X; Kang J; Yue J; Xu D; Liao C; Zhang H; Zhao J; Liu Q; Jiao J; Wang L; Li G Aging (Albany NY); 2023 May; 15(9):3442-3464. PubMed ID: 37142279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]